首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1332188篇
  免费   90937篇
  国内免费   3878篇
耳鼻咽喉   19014篇
儿科学   41040篇
妇产科学   36215篇
基础医学   190250篇
口腔科学   37691篇
临床医学   116880篇
内科学   255640篇
皮肤病学   30377篇
神经病学   100429篇
特种医学   51628篇
外国民族医学   283篇
外科学   202566篇
综合类   29760篇
现状与发展   2篇
一般理论   318篇
预防医学   87426篇
眼科学   31846篇
药学   107310篇
  8篇
中国医学   4483篇
肿瘤学   83837篇
  2021年   9737篇
  2019年   9976篇
  2018年   14801篇
  2017年   11532篇
  2016年   12804篇
  2015年   14302篇
  2014年   19574篇
  2013年   27901篇
  2012年   38165篇
  2011年   40059篇
  2010年   23701篇
  2009年   22234篇
  2008年   36945篇
  2007年   39740篇
  2006年   40155篇
  2005年   37818篇
  2004年   36020篇
  2003年   34566篇
  2002年   33264篇
  2001年   77064篇
  2000年   79009篇
  1999年   65544篇
  1998年   16182篇
  1997年   14043篇
  1996年   13613篇
  1995年   12723篇
  1994年   11460篇
  1993年   10810篇
  1992年   47974篇
  1991年   45621篇
  1990年   44693篇
  1989年   43033篇
  1988年   38948篇
  1987年   37785篇
  1986年   35502篇
  1985年   33164篇
  1984年   23789篇
  1983年   19887篇
  1982年   10812篇
  1979年   20901篇
  1978年   13854篇
  1977年   12402篇
  1976年   10542篇
  1975年   12087篇
  1974年   13987篇
  1973年   13500篇
  1972年   12862篇
  1971年   12207篇
  1970年   11157篇
  1969年   10803篇
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
1.
2.
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional...  相似文献   
3.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
4.

Physical activity brings significant health benefits to middle-aged adults, although the research to date has been focused on late adulthood. This study aims to examine how ageing affects the self-reported and accelerometer-derived measures of physical activity levels in middle-aged adults. We employed the data recorded in the UK Biobank and analysed the physical activity levels of 2,998 participants (1381 men and 1617 women), based on self-completion questionnaire and accelerometry measurement of physical activity. We also assessed the musculoskeletal health of the participants using the dual-energy X-ray absorptiometry (DXA) measurements provided by the UK Biobank. Participants were categorised into three groups according to their age: group I younger middle-aged (40 to 49 years), group II older middle-aged (50 to 59 years), and group III oldest middle-aged (60 to 69 years). Self-reported physical activity level increased with age and was the highest in group III, followed by group II and I (P?<?0.05). On the contrary, physical activity measured by accelerometry decreased significantly with age from group I to III (P?<?0.05), and the same pertained to the measurements of musculoskeletal health (P?<?0.05). It was also shown that middle-aged adults mostly engaged in low and moderate intensity activities. The opposing trends of the self-reported and measured physical activity levels may suggest that middle-aged adults over-report their activity level as they age. They should be aware of the difference between their perceived and actual physical activity levels, and objective measures would be useful to prevent the decline in musculoskeletal health.

  相似文献   
5.
6.
7.
8.
9.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号